The Food and Drug Administration on Wednesday approved Baxter International’s clindamycin injection in saline. Clindamycin is a common antibiotic used to treat serious infections when penicillin may ...

Growing demand for productive antibiotics in curing bacterial contamination, especially in hospital settings, is driving the market demand. The market includes several expressions and is impacted by a ...

Abraxis BioScience Receives FDA Approvals for Clindamycin Injection, USP LOS ANGELES -- Abraxis BioScience, Inc., an integrated, global biopharmaceutical company, today announced that it has received ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a global leader in sterile medication production and delivery, today announced the U.S. Food and Drug Administration (FDA) ...

The affected products were distributed to wholesalers between May 2016 and June 2017. Alvogen announced a voluntary recall of seven lots of Clindamycin Injection ADD-Vantage vials after detecting ...

Alvogen is voluntarily recalling seven lots of Clindamycin Injection USP ADD-Vantage Vials to the hospital/retail level due to microbial growth detected during a routine simulation of the ...

The company has voluntarily recalled Clindamycin Injection USP ADD-Vantage Vials to the hospital/retail level because of a lack of sterility assurance. On June 16, 2017, Alvogen announced it was ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

DEERFIELD - The U.S. Food and Drug Administration has approved the commercial launch of ready-to-use Baxter International's clindamycin injection in saline in three commonly prescribed formulation.